The inhaled product is a formulation of a naturally occurring protein that Synairgen has previously said may be deficient in those with greater susceptibility to Covid-19
London —
In a clinical trial involving 220 subjects, the probability of a patient requiring ventilation or dying dropped 79% for those who got Synairgen’s SNG001 versus those who received a placebo, the Southampton, England-based company said in a statement. Those receiving SNG001 also were more than twice as likely to fully recover from the illness, it added.
“We are expecting greater international interest because of the data that’s been produced today,” Marsden said. Synairgen rose 430% to 193.50 pence at 3.13pm London time. The stock’s latest surge takes its year-to-date gain to about 3,194%, giving Synairgen, which trades on London’s AIM venue for growth companies, a market capitalisation of about £289.2.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19 LIVE UPDATES | Rise in SA's Covid-19 cases continuesHealth minister Zweli Mkhize appealed to South Africans to do more to help break the cycle of infection.
Read more »
COVID-19 LIVE UPDATES | Gwede Mantashe hospitalised after testing positive for Covid-19Health minister Zweli Mkhize appealed to South Africans to do more to help break the cycle of infection.
Read more »
Synairgen shares soar after finding drug cuts Covid-19 severityThe inhaled product is a formulation of a naturally occurring protein that Synairgen has previously said may be deficient in those with greater susceptibility to Covid-19
Read more »
Government refuses to release Covid-19 advisories and data, while scientists plead for transparencyScientists say releasing the data would allow the public a chance to inform themselves on how the government formulates its policy, but government refuses to budge.
Read more »
COVID-19 LIVE UPDATES | Worldwide coronavirus cases cross 14.3 million, death toll at 600,497Covid-19 live coverage.
Read more »